Hypercholesterolemia and Myocardial function evaluated via Tissue Doppler Imaging

Cardiovascular Ultrasound

Volumn 7, Issue 1, 2009, Pages

  Rubinstein, Jack ^a   Pelosi, Augusta ^b   Vedre, Ameeth ^c   Kotaru, Pavan ^c   Abela, George S ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EZETIMIBE; CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; EUTHANASIA; GENERAL ANESTHESIA; HEART EJECTION FRACTION; HEART FUNCTION; HEART MUSCLE; HYPERCHOLESTEROLEMIA; MALE; MYOCARDIAL DISEASE; NONHUMAN; RABBIT; TISSUE DOPPLER IMAGING; TISSUE LEVEL; ANIMAL; BLOOD; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART LEFT VENTRICLE FUNCTION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; CHOLESTEROL; ECHOCARDIOGRAPHY, DOPPLER; HYPERCHOLESTEROLEMIA; MALE; MYOCARDIUM; RABBITS; VENTRICULAR FUNCTION, LEFT;

EID: 73849151076     PISSN: None     EISSN: 14767120     Source Type: Journal    
DOI: 10.1186/1476-7120-7-56     Document Type: Article

References (35)

1. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. W Rosamond K Flegal G Friday K Furie A Go K Greenlund N Haase M Ho V Howard B Kissela S Kittner D Lloyd-Jones M McDermott J Meigs C Moy G Nichol CJ O'Donnell V Roger J Rumsfeld P Sorlie J Steinberger T Thom S Wasserthiel-Smoller Y Hong, Circulation 2007 115 69 171 10.1161/CIRCULATIONAHA. 106.179918 17194875
2. Heart Failure. M Jessup S Brozena, N Engl J Med 2003 348 2007 18 10.1056/NEJMra021498 12748317
3. Lipids and risk of coronary heart disease. WP Castelli K Anderson PW Wilson D Levy, The Framingham Study. Annals of Epidemiology 2 23 8
4. Hypercholesterolemia promotes inflammation and microvascular dysfunction: Role of nitric oxide and superoxide. KY Stokes D Cooper A Tailor DN Granger, Free Radical Biology & Medicine 2002 33 1026 1036
5. Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project. J Simes CD Furberg E Braunwald BR Davis I Ford A Tonkin J Shepherd, Eur Heart J 2002 23 207 15 10.1053/euhj.2001.2775 11792135
6. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. K Kalantar-Zadeh G Block T Horwich GC Fonarow, J Am Coll Cardiol 2004 43 1439 44 10.1016/j.jacc.2003.11.039 15093881
7. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. GISSI-HF investigators, Lancet 2008 372 1231 9 10.1016/S0140-6736(08)61240-4 18757089
8. Obesity and heart failure prognosis: paradox or reverse epidemiology? CJ Lavie MR Mehra RV Milani, Eur Heart J 2005 26 5 7 10.1093/eurheartj/ehi055 15615792
9. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. SA Hunt WT Abraham MH Chin AM Feldman GS Francis TG Ganiats M Jessup MA Konstam DM Mancini K Michl JA Oates PS Rahko MA Silver LW Stevenson CW Yancy, Circulation 2005 112 154 235 10.1161/ CIRCULATIONAHA.105.167586 16160202
10. Tissue Doppler imaging a new prognosticator for cardiovascular diseases. C-M Yu JE Sanderson TH Marwick JK Oh, J Am Coll Cardiol 2007 49 1903 14 10.1016/j.jacc.2007.01.078 17498573
11. Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. H Dokainish WA Zoghbi NM Lakkis E Ambriz R Patel MA Quinones SF Nagueh, J Am Coll Cardiol 2005 45 1223 6 10.1016/j.jacc.2005.01.025 15837253
12. Independent and incremental prognostic value of early mitral annulus velocity in patients with impaired left ventricular systolic function. M Wang GWK Yip CM Yu Y Zhang Q Zhang MK Tse SL Kong JE Sanderson, J Am Coll Cardiol 2005 45 272 7 10.1016/j.jacc.2004.09.059 15653027
13. Heart failure with a normal ejection fraction. JE Sanderson, Heart 2007 93 155 8 10.1136/hrt.2005.074187 16387829
14. Triggering of Plaque Disruption and Arterial Thrombosis in an Atherosclerotic Rabbit Model. GS Abela PD Picon SE Friedl OC Gebara A Miyamoto M Federman GH Tofler JE Muller, Circulation 1995 91 776 84 7828306
15. The laboratory rabbit: an animal model of atherosclerosis research. AE Yanni, Laboratory animals 2004 38 246 56 10.1258/002367704323133628 15207035
16. Tissue Doppler Imaging Consistently Detects Myocardial Contraction and Relaxation Abnormalities, Irrespective of Cardiac Hypertrophy, in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy. SF Nagueh HA Kopelen DS Lim WA Zoghbi MA Quinones R Roberts AJ Marian, Circulation 2000 102 1346 50 10993850
17. M-mode and Doppler echocardiographic reference values for male New Zealand white rabbits. APN Fontes-Sousa C Bras-Silva C Moura JC Areias AF Leite-Moreira, Am J Vet Res 2006 67 1725 9 10.2460/ajvr.67.10.1725 17014323
18. Left ventricle I: general considerations, assessment of chamber size and function. C Vuille AE Weyman, Principles and Practice of Echocardiography Philadelphia, PA, USA: Lea & Febiger, Vuille C, Weyman AE, 2 1994 575 611
19. Cardiac Systolic and Diastolic Dysfunction After a Cholesterol-Rich Diet. Y Huang KE Walker F Hanley J Narula SR Houser TN Tulenko, Circulation 2004 109 97 102 10.1161/01.CIR.0000109213.10461.F6 14676147
20. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. HC Chiu A Kovacs RM Blanton X Han M Courtois CJ Weinheimer KA Yamada S Brunet H Xu JM Nerbonne MJ Welch NM Fettig TL Sharp N Sambandam KM Olson DS Ory JE Schaffer, Circ Res 2005 96 225 33 10.1161/01.RES.0000154079.20681.B9 15618539
21. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. JM McGavock I Lingvay I Zib T Tillery N Salas R Unger BD Levine P Raskin RG Victor LS Szczepaniak, Circulation 2007 116 1170 5 10.1161/CIRCULATIONAHA.106.645614 17698735
22. Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failure. V Zaca S Rastogi M Imai M Wang VG Sharov A Jiang S Goldstein HN Sabbah, J Am Coll Cardiol 2007 50 551 7 10.1016/j.jacc.2007.04.050 17678740 (Pubitemid 47126770)
23. Aortic constriction exacerbates atherosclerosis and induces cardiac dysfunction in mice lacking apolipoprotein E. J-H Wu J Hagaman S Kim RL Reddick N Maeda, Arterioscler Thromb Vasc Biol 2002 22 469 75 10.1161/hq0302.105287 11884292
24. Myocardial lipid accumulation in the diabetic heart. FL Ruberg, Circulation 2007 116 1110 2 10.1161/CIRCULATIONAHA.107.721860 17768302
25. Rosuvastatin in Older Patients with Systolic Heart Failure. J Kjekshus E Apetrei V Barrios M Böhm JGF Cleland JH Cornel P Dunselman C Fonseca A Goudev P Grande L Gullestad A Hjalmarson J Hradec A Jnosi G Kamensk M Komajda J Korewicki T Kuusi F Mach V Mareev JJV McMurray N Ranjith M Schaufelberger J Vanhaecke DJ van Veldhuisen F Waagstein H Wedel J Wikstrand for the CORONA Group, N Engl J Med 2007 357 2248 61 10.1056/NEJMoa0706201 17984166
26. The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease. J Kjekshus TR Pedersen AG Olsson O Faergeman K Pyörälä J Card Fail 1997 3 249 54 10.1016/S1071-9164(97)90022-1 9547437 (Pubitemid 127674856)
27. Effects of lipid-lowering drugs on left ventricular function and exercise tolerance in dyslipidemic coronary patients. M de Lorgeril P Salen L Bontemps P Belichard A Geyssant R Itti, J Cardiovasc Pharmacol 1999 33 473 8 10.1097/00005344-199903000-00018 10069684
28. Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). MG Dickinson JH Ip B Olshansky AS Hellkamp J Anderson JE Poole DB Mark KL Lee GH Bardy, Am Heart J 2007 153 573 8 10.1016/j.ahj.2007. 02.002 17383296
29. In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH5 in the rat and rhesus monkey through the identification of the active metabolites of SCH48461. M Van Heek CF France DS Compton RL Mcleod NP Yumibe KB Alton EJ Sybertz HR Davis Jr, J Pharmacol Exp Ther 8235 283 157 63
30. Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy. FA Masoudi SE Inzucchi, Am J Cardiol 2007 99 113B 132B 10.1016/j.amjcard.2006.11.013 17307064
31. Cardiac abnormalities in primary hemochromatosis. A Dabestani JS Child JK Peloff WG Figueroa HR Schelbert TR Engel, Ann N Y Acad Sci 1988 526 234 44 10.1111/j.1749-6632.1988.tb55509.x 3389642
32. Metabolic Mechanisms in Heart Failure. H Ashrafian MP Frenneaux LH Opie, Circulation 2007 116 434 48 10.1161/CIRCULATIONAHA.107.702795 17646594
33. Dietary Strategies for Improving Post-Prandial Glucose, Lipids, Inflammation, and Cardiovascular Health. JH O'Keefe NM Gheewala JO O'Keefe, J Am Coll Cardiol 2008 51 249 55 10.1016/j.jacc.2007.10.016 18206731
34. Diabetic cardiomyopathy: the search for a unifying hypothesis. IG Poornima P Parikh RP Shannon, Circ Res 2006 98 596 605 10.1161/01.RES. 0000207406.94146.c2 16543510
35. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. S Sharma JV Adrogue L Golfman I Uray J Lemm K Youker GP Noon OH Frazier H Taegtmeyer, FASEB J 2004 18 1692 1700 10.1096/fj.04-2263com 15522914